Connect with us

Legal & Regulation

USDA Issues Transportation of Hemp Memo Stating No Shipping Roadblocks Across State Lines



USDA Issues Transportation of Hemp Memo Stating No Shipping Roadblocks Across State Lines

The U.S. Department of Agriculture (USDA) released a memo on Tuesday to address several sections of the 2018 Farm Bill concerning the transportation of hemp in interstate commerce.

The memo, which is based on the legal opinion of the Office of the Attorney General, makes a number of conclusions, which are as follows:

First, hemp is no longer a Schedule I controlled substance under the Controlled Substances Act.

Second, after the USDA publishes regulations that implement the new hemp production provisions of the 2018 Farm Bill, which are contained in the Agricultural Marketing Act of 1946,

“States and Indian tribes may not prohibit interstate transportation or shipment of hemp lawfully produced under a State or Tribal plan or under a license issued under the USDA plan.”

Third, the interstate transportation or shipment of hemp lawfully produced under the 2014 Farm Bill cannot be prohibited by States and Indian tribes.

By the language, it seems that the USDA is planning on publishing regulations concerning new hemp production provisions. Before planting, harvesting, and processing of hemp crops per the new provisions can occur, the USDA must publish the regulations and approve regulatory plans submitted by the states.

The memo also adds that other agencies, such as the Secretary of the Health and Human Services and Commissioner of the Food and Drug Administration, also have a role in regulating hemp under applicable FDA laws. The memo states,

“It is also important to emphasize that the 2018 Farm Bill does not affect or modify the authority of the Secretary of Health and Human Services or Commissioner of Food and Drugs to regulate hemp under applicable U.S. Food and Drug Administration (FDA) laws. USDA expects to issue regulations implementing new hemp production authorities in 2019.”

Those who are interested in reading the memo can do so here.

Denis is one of the most experienced researchers for reviews we have with years of experience in writing about CBD products. He will be one of the most viewed authors due to his own thrill in sharing what he is learning about cannabidiol and supplement use. With a goal of providing clarity within the budding CBD oil industry, Denis will be spending much of the year going through a catalogue of cannabis oil companies in the near future.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.